CEP
PTCT icon

Chicago Equity Partners’s PTC Therapeutics PTCT Stock Holding History

Chicago Equity Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15,060
Closed -$508K – 864
2018
Q2 		$508K Sell
15,060
-2,600
-15% -$81.1K 0.02% 643
2018
Q1 		$478K Sell
17,660
-110
-0.6% -$2.79K 0.02% 616
2017
Q4 		$296K Hold
17,770
– – 0.01% 680
2017
Q3 		$356K Sell
17,770
-44,520
-71% -$872K 0.01% 663
2017
Q2 		$1.14M Buy
62,290
+5,270
+9% +$71K 0.03% 479
2017
Q1 		$561K Buy
+57,020
New +$690K 0.02% 566

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Chicago Equity Partners's PTCT Position: Q3 2018 in Review

Chicago Equity Partners sold out of PTC Therapeutics (PTCT) in Q3 2018, closing a stake of 15,060 shares — an estimated $508K sold.

Chicago Equity Partners first reported a position in PTCT in Q1 2017 and held it in 6 quarters. The position peaked at $1.14M in Q2 2017. 180 funds tracked by Wall St. Rank hold PTCT as of Q3 2018.

  • Chicago Equity Partners reported no remaining PTC Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Chicago Equity Partners sold 15,060 PTC Therapeutics shares in Q3 2018, an estimated $508K.
  • Chicago Equity Partners first reported a position in PTC Therapeutics in Q1 2017 and held it in 6 quarters.
  • Chicago Equity Partners's PTC Therapeutics position peaked at $1.14M in Q2 2017.
  • 180 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2018.

Based on Chicago Equity Partners's 13F filing for Q3 2018, filed 1 Nov 2018.